Breaking News

Cytovance Invests in Mass Spectrometry Services

CDMO has offered Mass Spec as an outsourced service for several years, but now has an in-house solution for clients.

By: Contract Pharma

Contract Pharma Staff

Cytovance Biologics, a biopharmaceutical contract development and manufacturing organization (CDMO), has added Mass Spectrometry (Mass Spec) to its Analytical Development suite of services. Cytovance has offered Mass Spec as an outsourced service for several years, but now as an in-house solution, the Analytical Team will be able to offer improved turnaround with more complete, reliable answers that better enable smarter decisions along the development path for biological therapeutic manufacturi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters